Vasopressors: Difference between revisions

Line 4: Line 4:
===Indication===
===Indication===
*Septic shock
*Septic shock
*Cardiogenic shock:
**If marked hypotension (SBP <70)
**If used with dobutamine
===Primary Receptor===
===Primary Receptor===
*α1 >> β1  
*α1 >> β1  

Revision as of 00:54, 10 January 2014


Norepinephrine

Indication

  • Septic shock
  • Cardiogenic shock:
    • If marked hypotension (SBP <70)
    • If used with dobutamine

Primary Receptor

  • α1 >> β1

Relative Effects

  • ↑↑↑SVR
  • ↑HR
  • ↑SV

Dosing

  • Start 2mcg/min
    • Incr by 1-2mcg/min
    • Max dose is 40mcg/min
  • Replace volume before starting

Rate of Titration

  • Q2-5 min

Adverse Effects

  • If extravasates use phentolamine 5-10mg into affected area

Notes

More potent vasoconstrictor than dopamine and phenylephrine.

Dopamine

Indication

  • Hypotension caused by:
    • Septic shock
    • MI
    • Trauma/spinal shock
    • Heart failure

Primary Receptor

  • Low dose: DA, β1
  • High dose: DA, α1 >> β1

Relative Effects

  • Low dose: Natriuresis, ↑↑HR, ↑↑SV
  • High dose: ↑SVR and ↑SV

Contraindication

  • Tachyarrhythmias

Dosing

  • Low dose:
    • 1-5 mcg/kg/min - Vasodilation (renal, mesenteric, coronary)
    • 5-10 mcg/kg/min - predominant β1
  • High dose: 10-20 mcg/kg/min - predominant α1
  • Titrate to clinical effect
    • Use lowest dose possible (prevent tachyphylaxis)
  • May use in peripheral IV temporarily
    • Avoid using in same line as alkaline infusions

Rate of Titration

  • Q2-5 min

Adverse Effects

  • Low doses:
    • Hypotension
  • High doses:
    • Hypertension, ectopic beats
  • Tissue necrosis (if extravasates)
    • If occurs use phentolamine 5-10mg in affected area

Dobutamine

Indication

  • Cardiogenic shock
  • Low-output heart failure
  • Tricyclic overdose

Primary Receptor

  • β1
  • β2

Relative Effects

  • ↑↑↑SV
  • ↑↑HR
  • ↓SVR (transient, from β2 agonism)

Dosing

  • 2-20mcg/kg/min
    • 10mcg works for most
  • May use in peripheral IV

Rate of Titration

  • Q2-5 min

Adverse Effects

  • Tachyarrhythmias
  • Myocardial ischemia
  • Hypotension as β2 effect may result in vasodilation
    • Caution if SBP <90

Phenylephrine

Indication

  • Neurogenic Shock

Primary Receptor

  • α1

Relative Effects

  • ↑SVR
  • ↓HR (reflex bradycardia)

Dosing

  • Start 100-200mcg/min then taper down
    • 40-60mcg/min works for most

Adverse Effects

  • Baroreceptor-mediated reflex bradycardia
  • If extravasates use phentolamine

Notes

  • Use with caution in pts with spinal cord injury-related bradycardia
  • Useful for treatment of vasodilatory shock when norepinephrine or dopamine have precipitated tachyarrhythmias
  • In pts with ↓LV function, unopposed α1 may lead to decreased CO or myocardial ischemia
    • However clinical trials do not support these effects when used in clinically appropriate dose range

Vasopressin

Indication

  • Adjunct for septic shock

Primary Receptor

  • V1

Relative Effects

  • ↑SVR
  • ↓HR

Dosing

  • 0.04 units/min

Rate of Titration

  • Fixed dose (do not titrate)

Adverse Effects

  • Bradycardia
  • Limb ischemia
  • Myocardial ischemia
  • Splanchnic ischemia

Notes

  • Adverse effects are dose-dependent
  • Acts on V1 receptors leading to ↑vasoconstriction and

↑sensitivity to catecholamines in pts with shock

Epinephrine

Indication

  • Anaphylaxis

Primary Receptor

  • β1
  • α1
  • β2

Relative Effects

  • ↑↑↑HR
  • ↑↑↑SV
  • ↑↑↑SVR
  • Bronchodilation (β2)

Dosing

  • Dose-dependent effects:
  • 1-10 mcg/min - increase HR and SV
  • 10-20 mcg/min - increase SVR

Rate of Titration

  • Q2-5 min

Adverse Effects

  • Tachyarrhythmias
  • Myocardial ischemia
  • ↑Serum lactate
  • Splanchnic ischemia

Notes

  • ↑lactate occurs primarily from ↑glycolysis/glycogenolysis within skeletal muscles not tissue hypoperfusion
  • Use with caution in pts with CAD
    • However clinical trials have not demonstrated worsened outcomes


Milrinone

Indication

Primary Receptor

  • PDE-3 inhibitor

Relative Effects

  • ↑HR
  • ↑↑↑SV
  • ↓SVR

Dosing

  • Normal renal function:

0.25 - 0.75 mcg/kg/min

  • Creatinine clearance < 50mL/min, reduce infusion rate

Rate of Titration

  • Q2H; slower titration rate if renal insufficiency

Adverse Effects

  • Tachyarrhythmias
  • Hypotension
  • Myocardial ischemia

Notes

  • Can use as alternative to dobutamine in pts with cardiogenic shock and on b-blockers
  • Causes pulmonary vasodilation, may be good choice in pts with RV failure
  • ↑cAMP in cardiac myocytes and vascular smooth muscle, thereby ↑HR and ↑SV while decreasing ↓SVR
  • Use with caution in pt with renal failure and hypovolemia

Push Dose Pressors

  • Use when need temporary BP or CO boost
    • Post-intubation hypotension
    • Propofol-induced hypotension
    • A-fib w/ hypotension
      • Easier to convert well-perfused heart

Epinephrine

  • Mix 9mL of NS with 1mL of 1:10,000 epi
    • Now have 10mL of 10mcg/mL
      • Use 0.5-2mL q2-5min (similar to epi drip)
      • Same as 2% lido with epi
        • Ok to give peripherally
  • Onset - 1min
  • Duration - 5-10min

Phenylephrine

  • Pure alpha (no effect on heart)
  • Place 1mL of 10mg/mL in 100mL NS
    • Draw up 10mL
      • Now have 100mcg/mL
    • Use 0.5-2mL q2-5min
  • Onset - 1min
  • Duration - 20min

Source

  • EBmedicine.net
  • Tintinalli
  • EmCrit Podcast 6